High-Dose Toremifene as a Promising Candidate Therapy for Hormone Receptor-Positive Metastatic Breast Cancer with Secondary Resistance to Aromatase Inhibitors
- DOI
- 10.1155/2020/7156574
- Published
- 2020-02-12
- Container
- International Journal of Breast Cancer
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1155/2020/7156574,
title = {High-Dose Toremifene as a Promising Candidate Therapy for Hormone Receptor-Positive Metastatic Breast Cancer with Secondary Resistance to Aromatase Inhibitors},
author = {Atsushi Fushimi and Isao Tabei and Azusa Fuke and Tomoyoshi Okamoto and Hiroshi Takeyama},
year = {2020},
journal = {International Journal of Breast Cancer},
doi = {10.1155/2020/7156574},
url = {https://doi.org/10.1155/2020/7156574}
}RIS
TY - JOUR TI - High-Dose Toremifene as a Promising Candidate Therapy for Hormone Receptor-Positive Metastatic Breast Cancer with Secondary Resistance to Aromatase Inhibitors AU - Atsushi Fushimi AU - Isao Tabei AU - Azusa Fuke AU - Tomoyoshi Okamoto AU - Hiroshi Takeyama PY - 2020 JO - International Journal of Breast Cancer DO - 10.1155/2020/7156574 UR - https://doi.org/10.1155/2020/7156574 ER -
APA
Fushimi, A., Tabei, I., Fuke, A., Okamoto, T., & Takeyama, H. (2020). High-Dose Toremifene as a Promising Candidate Therapy for Hormone Receptor-Positive Metastatic Breast Cancer with Secondary Resistance to Aromatase Inhibitors. International Journal of Breast Cancer. https://doi.org/10.1155/2020/7156574
Source records
- crossref · retrieved 2026-11-10T12:44:25.083Z